Skip to main content
Premium Trial:

Request an Annual Quote

A New Stage

The California Institute of Regenerative Medicine has a new strategic plan, reports the Nature News Blog. For the next five years, CIRM will shift its focus away from basic research toward clinical applications. "The first stage of CIRM was really exploring the field," says Ellen Feigal, the institute's senior vice president of R&D. "The next five years should be one of more focus." Nature adds that three-fifths of CIRM's $840 million budget for the next five years will go to clinical development research while the rest will fund basic and translational research.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.